- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | VITURA HEALTH LIMITED: Change in substantial holding | - | ASX | ||
| VITURA HEALTH Aktie jetzt für 0€ handeln | |||||
| Di | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
| 10.04. | VITURA HEALTH LIMITED: Response to ASX Letter about Director Trading | - | ASX | ||
| 07.03. | VITURA HEALTH LIMITED: S&P DJI Announces March 2025 Quarterly Rebalance | - | ASX | ||
| 04.03. | VITURA HEALTH LIMITED: Change of Director's Interest Notice | 1 | ASX | ||
| 28.02. | VITURA HEALTH LIMITED: Change of Director's Interest Notice | 1 | ASX | ||
| 28.02. | VITURA HEALTH LIMITED: Investor webinar and presentation | 2 | ASX | ||
| 25.02. | VITURA HEALTH LIMITED: Change of Director's Interest Notice | - | ASX | ||
| 24.02. | VITURA HEALTH LIMITED: Cleansing Notice | - | ASX | ||
| 24.02. | VITURA HEALTH LIMITED: Application for quotation of securities - VIT | - | ASX | ||
| 24.02. | VITURA HEALTH LIMITED: Vitura completes acquisition of Canview platform | - | ASX | ||
| 24.02. | VITURA HEALTH LIMITED: H1 FY2025 financial results | - | ASX | ||
| 24.02. | VITURA HEALTH LIMITED: 2025 Half-Year Financial Report | - | ASX | ||
| 24.02. | VITURA HEALTH LIMITED: Appendix 4D | - | ASX | ||
| 20.02. | VITURA HEALTH LIMITED: Vitura completes acquisition of Candor Medical | 2 | ASX | ||
| 17.02. | VITURA HEALTH LIMITED: Update - Proposed issue of securities - VIT | - | ASX | ||
| 17.02. | VITURA HEALTH LIMITED: Becoming a substantial holder - updated | - | ASX | ||
| 14.02. | VITURA HEALTH LIMITED: Change in substantial holding | - | ASX | ||
| 13.02. | VITURA HEALTH LIMITED: Change of Substantial Holder - G Headley | 2 | ASX | ||
| 12.02. | XFRA 1CE0: WIEDERAUFNAHME/RESUMPTION | 112 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen |
Seite:
1 2 3 Weiter >>
50 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 4,300 | +1,65 % | Aurora Cannabis Aktie: Ein neuer Lichtblick! | Der kanadische Cannabisproduzent positioniert sich durch internationale Markterschließung, technologische Innovation und solide Finanzlage für langfristiges Wachstum. Aurora Cannabis zieht weiterhin... ► Artikel lesen | |
| TILRAY BRANDS | 0,421 | -1,68 % | Tilray Aktie: Abwärtsdruck steigt! | Tilray erweitert Getränkesortiment mit neuem Whiskey, doch geplanter Reverse Split belastet die Aktie. Bleibt der Abwärtstrend ungebrochen? Whiskey-Release als DiversifikationsschrittAnzeigeSollten... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,008 | -0,83 % | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA 02.04.2025 | The following instruments on XETRA do have their first trading 02.04.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 02.04.2025
Aktien
1 ROMEDLACNOR6 MedLife S.A.
2 CA29872T2092... ► Artikel lesen | |
| SNDL | 1,309 | -0,53 % | SNDL Inc. Launches Rise Rewards Loyalty Program | ||
| MYDECINE INNOVATIONS GROUP | 0,002 | 0,00 % | Aquis Stock Exchange: Withdrawal from Trading - Mydecine Innovations Group Inc. | Aquis Stock Exchange
Aquis Stock Exchange: Withdrawal from Trading 02-Apr-2025 / 07:00 GMT/BST
The issuer is solely responsible for the content of this... ► Artikel lesen | |
| BIONANO GENOMICS | 4,350 | +2,35 % | Bionano Genomics: Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025 | SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2024 and revenue outlook... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 15,900 | +0,63 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress Washington 2025 | ||
| HIGH TIDE | 2,085 | -1,18 % | High Tide eröffnet einen neuen "Canna Cabana"-Laden in Cochrane, Alberta | Das Unternehmen berichtet außerdem über Neuigkeiten zu seinem Einstieg in den deutschen Markt für medizinisches
Cannabis
CALGARY, AB, 21. April 2025 / IRW-Press / High Tide Inc.... ► Artikel lesen | |
| JAGUAR HEALTH | 10,790 | +32,39 % | Jaguar Health, Inc. - 8-K, Current Report | ||
| ACHIEVE LIFE SCIENCES | 2,080 | -0,95 % | Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine | ORCA-3 Demonstrated a Significant Increase in Quitting and Reduction in Nicotine Cravings for Cytisinicline-Treated Participants Compared to Placebo Cytisinicline New Drug Application (NDA) Submission... ► Artikel lesen | |
| SEELOS THERAPEUTICS | 2,000 | 0,00 % | Delisting of Securities of Patria Latin American Opportunity Acquisition Corp.; Trevena, Inc.; Seelos Therapeutics, Inc.; DP Cap Acquisition Corp I; Chain Bridge I; Qomolangma Acquisition Corp.; Gaucho Group Holdings, Inc. ... | NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the Class A Ordinary Shares, unit, and warrant of Patria Latin American Opportunity Acquisition... ► Artikel lesen | |
| PLANTFUEL LIFE | 0,009 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 24.03.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 24.03.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 24.03.2025ISIN NameCA12571Q4034 CMC... ► Artikel lesen | |
| MEDIPHARM LABS | 0,052 | 0,00 % | MediPharm Labs Corp.: MediPharm Labs Reports Full Year & Fourth Quarter 2024 Results | Annual Net Revenue Increase of 27% to $42M, Driven by Record $18M International Medical Cannabis Revenue and Approaching Positive Adjusted EBITDA(1) for Q4. TORONTO, March 31, 2025 /PRNewswire/... ► Artikel lesen | |
| ARGENT BIOPHARMA | 0,084 | +1,82 % | ARGENT BIOPHARMA LIMITED: s708A Cleansing Notice | ||
| AYR WELLNESS | 0,229 | +3,86 % | Ayr Wellness Inc.: AYR Wellness Reports Fourth Quarter and Full Year 2024 Results | MIAMI, March 06, 2025 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) ("AYR" or the "Company"), a leading vertically integrated U.S. multi-state cannabis operator, is reporting financial... ► Artikel lesen |
VITURA HEALTH LIMITED gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell +2,08 % bei einem Aktienkurs von 0,025 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VITURA HEALTH LIMITED finden Sie auf Wallstreet Online.
